Louisiana 2016 Regular Session

Louisiana House Bill HB734

Introduced
3/4/16  
Introduced
3/4/16  
Refer
3/4/16  
Refer
3/4/16  
Refer
3/14/16  

Caption

Provides relative to certain procedures in civil proceedings

Impact

If enacted, HB734 would introduce limitations on the suspension of liberative prescription in class action cases. It clarifies that individual members of a class cannot rely on suspension benefits if they subsequently file a separate lawsuit unless that lawsuit is transferred and consolidated with the class action. This change aims to streamline the legal process by ensuring that courts handle all related claims in a unified manner, potentially reducing the complexity and duration of ongoing litigation concerning the same underlying issues.

Summary

House Bill 734 is a legislative proposal aimed at refining the procedures related to civil class action lawsuits in Louisiana. The bill specifically deals with the concept of 'liberative prescription,' which refers to the period within which legal action must be initiated before a claim is barred by law. Under the existing legal framework, prescription is suspended when a class action suit is filed on behalf of multiple claimants. HB734 seeks to amend this provision by adding the removal of a class action to federal court as a point at which the suspension of prescription ends. This means that once a case is moved to federal court, the time counts again towards the duration allowable for filing claims.

Sentiment

The sentiment surrounding HB734 appears to lean towards the support of legal efficiency and clarity in the class action process. Proponents of the bill argue that it provides necessary updates to civil procedure that will help prevent individual claimants from inadvertently prolonging the class action process or complicating adjudication. However, potential concerns have been raised regarding how these changes might affect the rights of individual claimants within class actions, as the proposed alterations could limit their legal recourse.

Contention

One of the primary points of contention regarding HB734 centers on its implications for individuals seeking to bring claims independently of class actions. Critics may argue that the bill could disadvantage those members who seek to address their individual claims outside of a class framework, especially in situations where a class action may not adequately represent their interests. The balance between facilitating efficient legal processes and safeguarding individual rights remains a critical discussion point as the bill progresses.

Companion Bills

No companion bills found.

Similar Bills

CA AB2789

Health care practitioners: prescriptions: electronic data transmission.

CA AB852

Health care practitioners: electronic prescriptions.

CA AB149

Controlled substances: prescriptions.

TX SB594

Relating to the regulation of prescriptions for controlled substances, including certain procedures applicable to electronic prescriptions for Schedule II controlled substances.

TX HB2246

Relating to certain procedures applicable to electronic prescriptions for Schedule II controlled substances.

TX HB2766

Relating to electronic and other controlled substance prescriptions under the Texas Controlled Substances Act; authorizing a fee.